Online ISSN: 2331-4737
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

MYC Amplification in Metastatic Prostate Cancer Associated with Reduced Tumor Immunogenicity

Oncoscience

March 11, 2026
A new research paper was published in Volume 13 of Oncoscience on February 7, 2026, titled “Reduced immunogenicity of MYC amplified, metastatic prostate cancer.” continue reading »

Rare Pancreatic Tumor Case Suggests Distinctive Calcification Patterns in Solid Pseudopapillary Neoplasms

Oncoscience

March 6, 2026
A new case report was published in Volume 13 of Oncoscienceon February 7, 2026, titled “Massive calcified solid pseudopapillary neoplasm of the pancreatic head.”  continue reading »

Gastrointestinal Toxicity Linked to Targeted Cancer Therapies in the United States

Oncoscience

February 20, 2026
A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled “Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection.” continue reading »

New Dual-Action Compound Reduces Pancreatic Cancer Cell Growth

Oncoscience

February 10, 2026
A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled “Dual targeting of oncogenic microtubules and mitochondria in PDAC.” continue reading »